NEW YORK (GenomeWeb News) – The Sloan-Kettering Institute, part of the Memorial Sloan-Kettering Cancer Center, has licensed Geneva Bioinformatics’ PhenyxServer protein identification and characterization software, GeneBio said today.
Under the agreement, Sloan-Kettering researcher Paul Tempst will use the Phenyx protein identification and characterization software in its Clinical Proteomic Technology Assessment for Cancer group.
The Phenyx identification and characterization software platform, which was developed through a partnership with the Swiss Institute of Bioinformatics, includes protein searches and comparison and quantitation of multiple results.
Financial terms of the agreement were not released.